The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells
Abstract
Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 ± 4.1% for chronic obstructive pulmonary disease versus 25.6 ± 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Impaired phagocytosis and clearance of cellular debris by airway macrophages in COPD result in persistent inflammation.
“Impaired phagocytosis and clearance of cellular debris by airway macrophages in COPD result in persistent inflammation (85, 104).”
From Aging and Lung Disease (2020) · cites this paper as [104]
Macrophages, which can produce multiple proinflammatory cytokines and secrete MMPs, are the most abundant cell type in the BAL fluid of COPD patients, and increased numbers correlate with disease severity.
“Specifically, macrophages, which can produce multiple proinflammatory cytokines and secrete MMPs, are the most abundant cell type in the BAL fluid of COPD patients, and increased numbers correlate with disease severity (85, 86, 104).”
From Aging and Lung Disease (2020) · cites this paper as [104]
Due to reduced immunity, coexisting comorbidities, and age-associated functional limitations, the incidence of severe sepsis and septic shock increases in older individuals.
“Due to reduced immunity, coexisting comorbidities, and age-associated functional limitations, the incidence of severe sepsis and septic shock increases in older individuals (104, 146).”
From Aging and Lung Disease (2020) · cites this paper as [104]
Citations
Cites
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.619 · Cited by 3,276
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Kasahara, Y., Tuder, R. M., Taraseviciene‐Stewart, L., Cras, T. D. L., Abman, S. H., Hirth, P., Waltenberger, J. L., & Voelkel, N. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10259 · Cited by 1,110
Savill, J., Hogg, N., Ren, Y., & Haslett, C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116019 · Cited by 818
Flow cytometry of apoptotic cell death
Vermes, I., Haanen, C., & Reutelingsperger, C. P. M. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00233-7 · Cited by 808
Pauwels, R., Buist, A. S., Calverley, P., Jenkins, C. R., Hurd, S. S., & Lenfant, C. J. M. (2001) · Respiratory Care · doi:10.1177/002013240104600806 · Cited by 614
Segura-Valdéz, M. D. L., Pardo, A., Gaxiola, M., Uhal, B. D., Becerril, C., & Selman, M. (2000) · CHEST Journal · doi:10.1378/chest.117.3.684 · Cited by 507
Trautmann, A., Akdiş, M., Kleemann, D., Altznauer, F., Simon, H., Graeve, T., Noll, M., Bröcker, E., Blaser, K., & Akdiş, C. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9199 · Cited by 494
Fadok, V. A., Warner, M. L., Bratton, D. L., & Henson, P. M. (1998) · PubMed · Cited by 406
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13572 · Cited by 373
Fadok, V. A., Warner, M. L., Bratton, D. L., & Henson, P. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6250 · Cited by 353
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5628 · Cited by 348
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213572 · Cited by 327
Induction of Apoptosis and Pulmonary Fibrosis in Mice in Response to Ligation of Fas Antigen
Hagimoto, N., Kuwano, K., Miyazaki, H., Kunitake, R., Fujita, M., Kawasaki, M., Kaneko, Y., & Hara, N. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.3.2893 · Cited by 290
Role of mesenchymal cell death in lung remodeling after injury.
Polunovsky, V. A., Chen, B., Henke, C., Snover, D. C., Wendt, C. H., Ingbar, D. H., & Bitterman, P. B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116578 · Cited by 212
HED, J., Halldén, G., Johansson, S., & Larsson, P. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90224-9 · Cited by 191
(1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90189-u · Cited by 163
Inflammation and Repair Processes in Chronic Obstructive Pulmonary Disease
Rennard, S. I. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.supplement_1.5 · Cited by 136
I, A. P., Reyes, E., Bernstein, E. D., MARTINEZ, B., Monserrat, J., IZQUIERDO, J. L., Callol, L., de Lucas, P., Álvarez-Sala, R., Álvarez-Sala, J. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2002015 · Cited by 120
A transformed human epithelial cell line that retains tight junctions post crisis
Cozens, A., Yezzi, M. J., Yamaya, M., Steiger, D. J., Wagner, J. A., Garber, S. S., Chin, L., Simon, E. M., Cutting, G. R., Gardner, P. I., et al. (1992) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631062 · Cited by 99
Alexis, N. E., Soukup, J. M., Nierkens, S., & Becker, S. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.2.l369 · Cited by 88
Bjerknes, R., & Bass�e, C.-F. (1984) · Annals of Hematology · doi:10.1007/bf00320205 · Cited by 81
Erwig, L., Gordon, S., Walsh, G. M., & Rees, A. J. (1999) · Blood · doi:10.1182/blood.v93.4.1406 · Cited by 71
(1992) · European Respiratory Journal · doi:10.1183/09031936.93.05010115 · Cited by 61
Phagocytosis of apoptotic cells by human macrophages: Analysis by multiparameter flow cytometry
Jersmann, H. P. A., Ross, K. A., Vivers, S., Brown, S. B., Haslett, C., & Dransfield, I. (2002) · Cytometry Part A · doi:10.1002/cyto.a.10005 · Cited by 60
D’Agostino, P., Ferlazzo, V., Milano, S., Rosa, M. L., Bella, G. D., Caruso, R., Barbera, C., Grimaudo, S., Tolomeo, M., Feo, S., et al. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00100-x · Cited by 54
Role of Connective Tissue Proteases in the Pathogenesis of Chronic Inflammatory Lung Disease
Gadek, J. E., Fells, G. A., Zimmerman, R. L., & Crystal, R. G. (1984) · Environmental Health Perspectives · doi:10.1289/ehp.8455297 · Cited by 46
Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitis
Hansen, P. R. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00115-1 · Cited by 39
Hodge, S. J., Hodge, G. L., Flower, R. L., Reynolds, P. N., Scicchitano, R., & Holmes, M. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01120.x · Cited by 33
Self-citationThe macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease.
Ferrara, F., D'Adda, D., Falchi, M., & Dall'Asta, L. (1996) · PubMed · Cited by 31
Pruzanski, W., & Saito, S. (1988) · Inflammation · doi:10.1007/bf00915894 · Cited by 23
Meloni, F., Ballabio, P., Bianchi, L. N. C., Mangiarotti, P., Grassi, G., Bignamini, A., & Grassia, G. G. (2009) · Respiration · doi:10.1159/000196512 · Cited by 20
Role of Connective Tissue Proteases in the Pathogenesis of Chronic Inflammatory Lung Disease
Gadek, J. E., Fells, G. A., Zimmerman, R. L., et al. (1984) · Environmental Health Perspectives · doi:10.2307/3429709 · Cited by 11
Neutrophils Injure Bronchial Epithelium after Ozone Exposure
McDonald, R. J., & Usachencko, J. (1999) · Inflammation · doi:10.1023/a:1020291617820 · Cited by 6
Flagged first, then by citations
Research works printed but not linked: 1
- Gibson P, 1997, Pulmonary macrophage phagocytosis of apoptotic neutrophils is mediated by thrombospondin and its receptors‐avb3 and CD36, Am. J. Respir. Crit. Care Med., 155, A296
Cited by
Sorted by citations
Molecular mechanisms of necroptosis: an ordered cellular explosion
Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., & Kroemer, G. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2970 · Cited by 2,382
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,863
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,797
Apoptotic cell clearance: basic biology and therapeutic potential
Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223
The clearance of dead cells by efferocytosis
Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 924
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
Cosío, M. G., Saetta, M. P., & Agustí, A. G. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804752 · Cited by 821
Apoptosis and necrosis: Detection, discrimination and phagocytosis
Krysko, D. V., Berghe, T. V., D'Herde, K. G. M. A., & Vandenabeele, P. (2008) · Methods · doi:10.1016/j.ymeth.2007.12.001 · Cited by 707
Cigarette Smoking and Inflammation
Lee, J., Taneja, V., & Vassallo, R. (2011) · Journal of Dental Research · doi:10.1177/0022034511421200 · Cited by 701
“…interface with the immune system at the mucosal surfaces lining the oral cavity, sinuses, and airways. cigarette smoking and Inflammation: cellular and Molecular Mechanisms Thousands of ROS are produced in the burning cigarette and are not removed by cigarette butt filters (Huang et al., 2005).”
BackgroundInfluentialStrzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15051033 · Cited by 557
“Disturbed efferocytosis with abnormal accumulation of apoptotic epithelial cells in the airway lumen has been conclusively documented in COPD patients [216].”
BackgroundMultifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Chung, K. F., & Adcock, I. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00018908 · Cited by 613
Clearance of apoptotic cells: implications in health and disease
Elliott, M. R., & Ravichandran, K. S. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201004096 · Cited by 568
“Based on work from many laboratories over the past decade, several broadly defined steps have been identified in the recognition and removal of apoptotic cells by phagocytes.”
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema
Demedts, I., Demoor, T., Bracke, K. R., Joos, G., & Brusselle, G. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-53 · Cited by 543
“Others have suggested that humoral- and CD4+ celldependent mechanisms can lead to alveolar septal cell apoptosis and the development of emphysema [51].”
BackgroundPathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Yoshida, T., & Tuder, R. M. (2007) · Physiological Reviews · doi:10.1152/physrev.00048.2006 · Cited by 514
“In COPD patients, macrophage efferocytosis of apoptotic 16HBE airway epithelial cells was significantly decreased when compared with control macrophages (119).”
ResultPhagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166517.18801.a7 · Cited by 509
Cellular and molecular mechanisms of asthma and COPD
Barnes, P. J. (2017) · Clinical Science · doi:10.1042/cs20160487 · Cited by 525
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.004 · Cited by 508
“COPD macrophages are also defective in taking up apoptotic cells and this may contribute to the failure to resolve inflammation in COPD.(30) The nature of this defect in phagocytosis is not fully understood, but it seems to be caused by a defect in microtubular function that is required for phagocytosis rather than an…”
BackgroundPulmonary macrophages: key players in the innate defence of the airways
Byrne, A. J., Mathie, S. A., Gregory, L. G., & Lloyd, C. M. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207020 · Cited by 499
Segal, L. N., Alekseyenko, A. V., Clemente, J. C., Kulkarni, R., Wu, B., Chen, H., Berger, K. I., Goldring, R. M., Rom, W. N., Blaser, M. J., et al. (2013) · Microbiome · doi:10.1186/2049-2618-1-19 · Cited by 482
“In addition, it is plausible that the progressive immune dysfunction of COPD changes the lung microbiome [52,53].”
BackgroundExacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 465
Cho, S. J., & Stout-Delgado, H. W. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034610 · Cited by 458
“Due to reduced immunity, coexisting comorbidities, and age-associated functional limitations, the incidence of severe sepsis and septic shock increases in older individuals (104, 146).”
BackgroundInfluentialVandivier, R. W., Henson, P. M., & Douglas, I. S. (2006) · CHEST Journal · doi:10.1378/chest.129.6.1673 · Cited by 450
Animal models of chronic obstructive pulmonary disease
Wright, J. L., Cosío, M. G., & Churg, A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90200.2008 · Cited by 463
Crim, C. C., Calverley, P. M., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Willits, L. R., Yates, J., & Vestbo, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00193908 · Cited by 428
Secondary necrosis: The natural outcome of the complete apoptotic program
Silva, M. T. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.046 · Cited by 432
Vascular endothelial growth factor in the lung
Voelkel, N. F., Vandivier, R. W., & Tuder, R. M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00185.2005 · Cited by 412
Ritchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 403
Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease
Lugg, S. T., Scott, A., Parekh, D., Naidu, B. V., & THICKETT, D. R. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216296 · Cited by 416
The Neutrophil in Chronic Obstructive Pulmonary Disease. Too Little, Too Late or Too Much, Too Soon?
Hoenderdos, K., & Condliffe, A. M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0492tr · Cited by 389
Aeroparticles, Composition, and Lung Diseases
Falcón-Rodríguez, C. I., Osornio-Vargas, Á. R., Sada‐Ovalle, I., & Segura-Medina, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00003 · Cited by 403
“Exacerbation of COPD could be caused by bacteria, viruses (84), cigarette smoking (85), and exposure to indoor and outdoor air pollution (86).”
BackgroundAlveolar Macrophages as Orchestrators of COPD
Barnes, P. J. (2004) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-120028701 · Cited by 361
“Alveolar macrophages form COPD patients show defective phagocytosis of apoptotic airway epithelial cells (91).”
BackgroundDefective macrophage phagocytosis of bacteria in COPD
Taylor, A. E., Finney‐Hayward, T. K., Quint, J. K., Thomas, C. M. R., Tudhope, S. J., Wedzicha, J. A., Barnes, P. J., & Donnelly, L. (2009) · European Respiratory Journal · doi:10.1183/09031936.00036709 · Cited by 370
“4 Alveolar macrophages from COPD patients phagocytose fewer apoptotic epithelial cells [12] and Escherichia coli [13] compared with nonsmokers and less H.”
BackgroundResultSmoking Alters Alveolar Macrophage Recognition and Phagocytic Ability
Hodge, S. J., Hodge, G. L., Ahern, J., Jersmann, H. P. A., Holmes, M., & Reynolds, P. N. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0025oc · Cited by 357
Self-citationMolecular Mechanisms and Pathophysiology of Necrotic Cell Death
Vanlangenakker, N., Berghe, T. V., Krysko, D. V., Festjens, N., & Vandenabeele, P. (2008) · Current Molecular Medicine · doi:10.2174/156652408784221306 · Cited by 347
Cell Death in the Lung: The Apoptosis–Necroptosis Axis
Sauler, M., Bazan, I. S., & Lee, P. J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114320 · Cited by 327
“The high percentage of observed apoptotic cells may also occur as a consequence of ineffective macrophage efferocytosis in COPD (37).”
BackgroundC-type lectins and phagocytosis
Kerrigan, A. M., & Brown, G. D. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.003 · Cited by 343
“The MR has also been implicated in the phagocytic uptake of apoptotic cells in COPD (Hodge et al., 2003).”
BackgroundAlveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection
Allard, B., Panariti, A., & Martin, J. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01777 · Cited by 341
“In addition to asthma (27, 29), defective phagocytic function has been described in chronic obstructive pulmonary disease (30),”
BackgroundNeutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?
Porto, B. N., & Stein, R. T. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00311 · Cited by 327
“However, COPD subjects present lower numbers of alveolar macrophages (81) and these macrophages are defective in phagocytosis (83), which may explain the persistence of NETs in the airways.”
BackgroundProgrammed cell death and its role in inflammation
Yang, Y., Jiang, G., Zhang, P., & Fan, J. (2015) · Military Medical Research · doi:10.1186/s40779-015-0039-0 · Cited by 306
“AIM: Absent in melanoma; ALI: Acute lung injury; AM: Alveolar macrophages; ANT: Adenine nucleotide translocase; BAI: Brain-specific angiogenesis inhibitor; CARD: Caspase activation and recruitment domains; CLP: Cecal ligation and puncture; COPD: Chronic obstructive pulmonary disease; CYPD: Cyclophilin D; DAMPs: Damage…”
BackgroundClearance of apoptotic and necrotic cells and its immunological consequences
Krysko, D. V., D’Herde, K., & Vandenabeele, P. (2006) · Apoptosis · doi:10.1007/s10495-006-9527-8 · Cited by 316
“Defective or inefficient clearance of dying cells may contribute to persistence of inflammation and excessive tissue injury, as well as several different human pathologies, including systemic lupus erythematosus (SLE) [182–184], cystic fibrosis [185], chronic obstructive pulmonary disease [186] and diabetes [187].”
BackgroundMonocytes and Macrophages in COVID-19
Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 279
Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD
Raby, K. L., Michaeloudes, C., Tonkin, J., Chung, K. F., & Bhavsar, P. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1201658 · Cited by 300
Hodge, S. J., Hodge, G. L., Jersmann, H. P. A., Matthews, G. M., Ahern, J., Holmes, M., & Reynolds, P. N. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1666oc · Cited by 258
Self-citationParticulate matter air pollution and respiratory impact on humans and animals
Losacco, C., & Perillo, A. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-3344-9 · Cited by 251
Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation
Hodge, S. J., Hodge, G. L., Holmes, M., & Reynolds, P. N. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00077604 · Cited by 244
Self-citationOxidative Stress in COPD: Sources, Markers, and Potential Mechanisms
McGuinness, A., & Sapey, E. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020021 · Cited by 243
“In COPD, there is evidence of altered monocyte and monocyte derived macrophage function, including reduced phagocytosis [77] and an increased inflammatory cytokine output (IL1β and IL12) [78].”
BackgroundMichlewska, S., Dransfield, I., Megson, I. L., & Rossi, A. G. (2008) · The FASEB Journal · doi:10.1096/fj.08-121228 · Cited by 239
Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications
Silva, M. T., do Vale, A., & dos Santos, N. M. S. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0187-8 · Cited by 235
“Alveolar macrophages from patients with COPD are deficient in the capacity to engulf apoptotic cells [221], deficiency that is aggravated by smoking [222].”
BackgroundKang, M., Lee, C. G., Lee, J.-Y., Cruz, C. S. D., Chen, Z. J., Enelow, R. I., & Elias, J. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32709 · Cited by 218
Morimoto, K., Janssen, W. J., Fessler, M. B., McPhillips, K. A., Borges, V. M., Bowler, R. P., Xiao, Y., Kench, J. A., Henson, P. M., & Vandivier, R. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7657 · Cited by 215
“Discussion Apoptotic cell clearance defects are increasingly recognized in diseases of chronic inflammation (31, 32) and autoimmunity (33, 34, 67, 68), suggesting that effective efferocytosis may be necessary for the maintenance of homeostasis.”
BackgroundInfluentialNeutrophil extracellular traps are associated with inflammation in chronic airway disease
Wright, T. K., Gibson, P. G., Simpson, J. L., McDonald, V. M., Wood, L. G., & Baines, K. J. (2016) · Respirology · doi:10.1111/resp.12730 · Cited by 214
Berenson, C. S., Garlipp, M. A., Grove, L., Maloney, J., & Sethi, S. (2006) · The Journal of Infectious Diseases · doi:10.1086/508428 · Cited by 217
“However, related studies have demonstrated diminished phagocytic abilities of alveolar macrophages from persons with COPD, as well as of apoptotic airway cells, during Candida albicans infection [25, 32].”
BackgroundInflammation mechanism and research progress of COPD
Xu, J., Zeng, Q., Li, S., Su, Q., & Fan, H. X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404615 · Cited by 236
Alveolar lipids in pulmonary disease. A review
Agudelo, C. W., Samaha, G., & García‐Arcos, I. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01278-8 · Cited by 204
“Efferocytosis is necessary for elimination of airway apoptotic cells that if not removed, can eventually necrotize and lead to chronic inflammation [112].”
BackgroundSurfactant Proteins A and D Suppress Alveolar Macrophage Phagocytosis via Interaction with SIRPα
Janssen, W. J., McPhillips, K. A., Dickinson, M. G., Linderman, D. J., Morimoto, K., Xiao, Y. Q., Oldham, K. M., Vandivier, R. W., Henson, P. M., & Gardai, S. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1661oc · Cited by 203
The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Curtis, J. L., Freeman, C. M., & Hogg, J. C. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-002fm · Cited by 190
“This capacity appears to be further reduced in COPD, with attendant increased apoptotic cell accumulation (52, 53).”
BackgroundDefective Phagocytosis in Airways Disease
Donnelly, L., & Barnes, P. J. (2012) · CHEST Journal · doi:10.1378/chest.11-2348 · Cited by 196
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Hodge, S. J., Hodge, G. L., Brozyna, S., Jersmann, H. P. A., Holmes, M., & Reynolds, P. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00001506 · Cited by 190
Self-citationNeutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy
Keir, H. R., & Chalmers, J. D. (2022) · European Respiratory Review · doi:10.1183/16000617.0241-2021 · Cited by 185
The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing
Jun, J.-I., Kim, K.-H., & Lau, L. F. (2015) · Nature Communications · doi:10.1038/ncomms8386 · Cited by 173
Desch, A. N., Gibbings, S. L., Goyal, R., Kolde, R., Bednarek, J., Bruno, T. C., Slansky, J. E., Jacobelli, J., Mason, R. J., Ito, Y., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1376oc · Cited by 172
“The mannose receptor has also been implicated in the clearance of apoptotic cells in patients with COPD, where alveolar macrophages express less CD206 compared with alveolar macrophages from healthy control subjects (44).”
BackgroundProtracted bacterial bronchitis: The last decade and the road ahead
Chang, A. B., Upham, J. W., Masters, I. B., Redding, G., Gibson, P. G., Marchant, J. M., & Grimwood, K. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23351 · Cited by 171
“Deficient efferocytosis (impaired clearance of apoptotic cells by alveolar macrophages) 77 is another possible mechanism in PBB pathobiology.”
BackgroundHodge, S. J., Matthews, G. M., Mukaro, V. R., Ahern, J., Shivam, A., Hodge, G. L., Holmes, M., Jersmann, H. P. A., & Reynolds, P. N. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0459oc · Cited by 164
Self-citationCigarette Smoke Impairs Clearance of Apoptotic Cells through Oxidant-dependent Activation of RhoA
Richens, T. R., Linderman, D. J., Horstmann, S. A., Lambert, C. L., Xiao, Y., Keith, R. L., Boé, D. M., Morimoto, K., Bowler, R. P., Day, B. J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1148oc · Cited by 155
“However, because apoptotic cells are normally removed as rapidly as they are produced (66), increased numbers of apoptotic cells in the lungs and sputum of patients with COPD suggest both that cell death may be increased (60, 67) and that removal of these cells by phagocytosis (efferocytosis) or egression may be decre…”
BackgroundZheng, T., Kang, M., Crothers, K. A., Zhu, Z., Liu, W. Q., Lee, C. G., Rabach, L. A., Chapman, H. A., Homer, R., Aldous, D., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8106 · Cited by 152
“However, it is known that macrophages from patients with COPD have a defect in the phagocytosis of apoptotic epithelial cells and that cigarette smoke compromises macrophage phagocytosis of apoptotic neutrophils (48, 49).”
BackgroundHuynh, M.-L. N., Malcolm, K. C., Kotaru, C., Tilstra, J. A., Westcott, J. Y., Fadok, V. A., & Wenzel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-035oc · Cited by 151
Macrophage Heterogeneity in Respiratory Diseases
Boorsma, C. E., Draijer, C., & Melgert, B. N. (2013) · Mediators of Inflammation · doi:10.1155/2013/769214 · Cited by 156
“microorganisms but also appears to be present forM2-related phagocytic functions such as efferocytosis and mannose receptor-mediated uptake [136, 137].”
BackgroundGrabiec, A. M., & Hussell, T. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0555-3 · Cited by 148
“Uptake of apoptotic bronchial epithelial cells and neutrophils is significantly reduced in bronchoalveolar lavage macrophages from patients with COPD compared to healthy controls [21, 22, 79] , and this defect is more pronounced in COPD patients who currently smoke [22] .”
BackgroundPhipps, J. C., Aronoff, D. M., Curtis, J. L., Goel, D., O’Brien, E., & Mancuso, P. (2009) · Infection and Immunity · doi:10.1128/iai.00963-09 · Cited by 142
Berenson, C. S., Kruzel, R. L., Eberhardt, E., & Sethi, S. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit400 · Cited by 142
“Dysfunctional phagocytosis of alveolarmacrophages of smokers with COPD for apoptotic bronchial epithelial cells is also reported, raising questions of the specificity of the phagocytic defect [23].”
BackgroundDysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases
Saint‐Criq, V., Lugo‐Villarino, G., & Thomas, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101235 · Cited by 152
“For instance, elder individuals with poor lung function are prone to develop cardiovascular disease, type 2 diabetes (T2D) and cognitive decline, when compared to those individuals with robust lung function (Bowdish, 2019; Hole et al., 1996; Lange et al., 1990; Weiss et al., 1995).”
Pathogenesis of Chronic Obstructive Pulmonary Disease
MacNee, W. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.06.008 · Cited by 134
Lung Macrophage Phenotypes and Functional Responses: Role in the Pathogenesis of COPD
Yamasaki, K., & van Eeden, S. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020582 · Cited by 145
“However, COPD macrophages showed no defect in the non-specific phagocytosis of latex beads [43,49], suggesting a defect in receptor- or opsonization-mediated phagocytosis.”
BackgroundDefective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages
Belchamber, K. B. R., Singh, R., Batista, C., Whyte, M. K. B., Dockrell, D. H., Kilty, I., Robinson, M. J., Wedzicha, J. A., Barnes, P. J., & Donnelly, L. (2019) · European Respiratory Journal · doi:10.1183/13993003.02244-2018 · Cited by 143
“However, in COPD, alveolar macrophages are defective at phagocytosis of bacteria, fungal spores, and apoptotic epithelial cells [8-10].”
BackgroundCell Death, Remodeling, and Repair in Chronic Obstructive Pulmonary Disease?
Henson, P. M., Vandivier, R. W., & Douglas, I. S. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-104sf · Cited by 135
“, the process of efferocytosis) compared with uptake of polystyrene beads (2).”
BackgroundChapter 16 Methods for Distinguishing Apoptotic from Necrotic Cells and Measuring Their Clearance
Krysko, D. V., Berghe, T. V., Parthoens, E., D'Herde, K. G. M. A., & Vandenabeele, P. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01416-x · Cited by 132
Zhang, W., Zhao, J., Wang, R., Jiang, M., Ye, Q., Smith, A. D., Chen, J., & Shi, Y. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13256 · Cited by 132
Chandra, J., McCormick, T. S., Imamura, Y., Mukherjee, P. K., & Ghannoum, M. A. (2007) · Infection and Immunity · doi:10.1128/iai.01841-06 · Cited by 131
“interfere with cell viability (17) and that this dye can be used in conjunction with”
BackgroundImpaired macrophage phagocytosis in non‐eosinophilic asthma
Simpson, J. L., Gibson, P. G., Yang, I. A., Upham, J. W., James, A., Reynolds, P. N., & Hodge, S. J. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04075.x · Cited by 129
Self-citationCharacterisation of lung macrophage subpopulations in COPD patients and controls
Dewhurst, J. A., Lea, S., Hardaker, E. L., Dungwa, J. V., Ravi, A., & Singh, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-07101-2 · Cited by 125
Foronjy, R., Nkyimbeng, T., Wallace, A. M. R., Thankachen, J., Okada, Y., Lemaitre, V., & D'Armiento, J. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00481.2007 · Cited by 119
“Animal models have shown that macrophages are critical to the development of smoke-induced emphysema (18, 35, 40), and changes in macrophage biology have been well documented in COPD patients (6, 20, 38).”
Impaired macrophage phagocytosis of bacteria in severe asthma
Liang, Z., Zhang, Q., Thomas, C. M. R., Chana, K. K., Gibeon, D. S., Barnes, P. J., Chung, K. F., Bhavsar, P. K., & Donnelly, L. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-72 · Cited by 115
“In chronic obstructive pulmonary disease (COPD), a number of studies have shown defects in both bacterial clearance [14,15] and efferocytosis [16] indicating impaired macrophage innate responses.”
BackgroundRole of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases
Michaeloudes, C., Bhavsar, P. K., Mumby, S. E., Xu, B., Hui, C., Chung, K. F., & Adcock, I. M. (2019) · Journal of Innate Immunity · doi:10.1159/000504344 · Cited by 115
Development and Functions of Alveolar Macrophages
Woo, Y. D., Jeong, D., & Chung, D. H. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0058 · Cited by 110
“This difference may contribute to chronic inflammation in patients with respiratory diseases (Fitzpatrick et al., 2008; Hodge et al., 2003).”
BackgroundMacrolides as immunomodulatory medications for the therapy of chronic lung diseases
López-Boado, Y. S., & Rubin, B. K. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.01.010 · Cited by 111
Pneumonic and Nonpneumonic Exacerbations of COPD
Huerta, A. H., Crisafulli, E., Menéndez, R., Martínez, R., Soler, N., Guerrero, M., Montull, B., & Torres, A. (2013) · CHEST Journal · doi:10.1378/chest.13-0488 · Cited by 109
Bacteria Challenge in Smoke-exposed Mice Exacerbates Inflammation and Skews the Inflammatory Profile
Gaschler, G. J., Škrtić, M., Zavitz, C. C. J., Lindahl, M., Önnervik, P., Murphy, T. F., Sethi, S., & Stämpfli, M. R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1306oc · Cited by 109
Dual Role of Toll-Like Receptors in Asthma and Chronic Obstructive Pulmonary Disease
Bezemer, G. F. G., Sagar, S., van Bergenhenegouwen, J., Georgiou, N., Garssen, J., Kraneveld, A. D., & Folkerts, G. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004622 · Cited by 110
Increased Airway Granzyme b and Perforin in Current and Ex-Smoking COPD Subjects
Hodge, S. J., Hodge, G. L., Nairn, J., Holmes, M., & Reynolds, P. N. (2006) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550600976868 · Cited by 107
“BAL was obtained via flexible bronchoscopy, as we have previously described (16).”
MethodSelf-citationSharma, G., Hanania, N. A., & Shim, Y. M. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200904-022rm · Cited by 105
“In addition, the phagocystosis of apoptotic cells by airway macrophages is impaired in patients with COPD, and the resulting decreased clearance of already recruited inflammatory cells results in persistent antigenic stimuli and inflammation (76).”
BackgroundMortaz, E., Adcock, I. M., Ricciardolo, F. L. M., Varahram, M., Jamaati, H., Velayati, A. A., Folkerts, G., & Garssen, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136455 · Cited by 108
“Defective phagocytosis is an important defect contributing to the pathobiology of COPD [49,50].”
Sphingolipid-mediated Inhibition of Apoptotic Cell Clearance by Alveolar Macrophages
Petrusca, D. N., Gu, Y., Adamowicz, J. J., Rush, N. I., Hubbard, W. C., Smith, P., Berdyshev, E. V., Birukov, K. G., Lee, C., Tuder, R. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137604 · Cited by 104
Apoptosis in lung injury and remodeling
Li, X., Shu, R., Filippatos, G. S., & Uhal, B. D. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00519.2004 · Cited by 101
“Given the important roles of inflammation in the pathogenesis of COPD (78), much interest was generated by the findings of reduced apoptosis in neutrophils of COPD patients (83) and a reduced capacity of macrophages toward phagocytosis of apoptotic epithelial cells (40).”
BackgroundEltboli, O., Bafadhel, M., Hollins, F., Wright, A. K. A., Hargadon, B., Kulkarni, N., & Brightling, C. E. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-112 · Cited by 100
“Impaired phagocytic ability of macrophages is consistently observed in COPD [9-14] and asthma [15], but whether this”
BackgroundClearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis
Fond, A. M., & Ravichandran, K. S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_2 · Cited by 97
“The alveolar macrophages from patients with COPD exhibit defective engulfment capacity in vitro, corresponding to the increase in free apoptotic cells in the lungs of these patients(Hodge et al., 2003).”
BackgroundGao, W. Q., Yuan, C., Zhang, J., Li, L., Yu, L., Wiegman, C., Barnes, P. J., Adcock, I. M., Huang, M., & Yao, X. (2015) · Clinical Science · doi:10.1042/cs20150273 · Cited by 99
Altered Macrophage Function in Chronic Obstructive Pulmonary Disease
Hiemstra, P. S. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201305-123aw · Cited by 104
Macrophage Dysfunction in Respiratory Disease
Belchamber, K. B. R., & Donnelly, L. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-54090-0_12 · Cited by 94
Ryan, E. M., Sadiku, P., Coelho, P., Watts, E., Zhang, A., Howden, A. J. M., Sánchez-García, M. A., Bewley, M. A., Cole, J., McHugh, B. J., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0482oc · Cited by 98
Ween, M. P., Whittall, J. J., Hamon, R., Reynolds, P. N., & Hodge, S. J. (2017) · Physiological Reports · doi:10.14814/phy2.13370 · Cited by 93
“These findings implicate defective efferocytosis with secondary necrosis and potentiation of the inflammatory milieu (Hodge et al. 2003, 2005).”
BackgroundSelf-citationMolecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review
Ghanei, M., & Harandi, A. A. (2011) · Inhalation Toxicology · doi:10.3109/08958378.2011.576278 · Cited by 89
Metadata
- Authors
- Hodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M.
- Affiliations
- Royal Adelaide Hospital (AU)
- Women's and Children's Hospital (AU)
- Venue
- Immunology & Cell Biology
- Publisher
- Wiley
- Published
- 2003-08
- Volume
- 81
- Issue
- 4
- Pages
- 289-296
- ISSN
- 0004-945X (ISSN-L)
- 0818-9641
- 1440-1711
- OpenAlex
- W1980191732
- Cited by
- 440
- References
- 32
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 17 · 2023: 12 · 2022: 17 · 2021: 34 · 2020: 19 · 2019: 17 · 2018: 23 · 2017: 21 · 2016: 28 · 2015: 28 · 2014: 13 · 2013: 32 · 2012: 20
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunology and Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Royal Adelaide Hospital
- Australian Lung Foundation
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- chronic obstructive pulmonary disease, alveolar macrophages, phagocytosis, cigarette smoke, 16HBE cells, MitoTracker Green, CD33, phagocytic defects
- MeSH terms
- Aged, Antibodies, Monoclonal, Bronchoalveolar Lavage Fluid, Cell Line, Transformed, Cell Survival, Epithelial Cells, Flow Cytometry, Humans, Phagocytosis, Macrophages, Alveolar, Apoptosis, Respiratory Mucosa, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review